Live Breaking News & Updates on Revelation Partners

Stay updated with breaking news from Revelation partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

San Diego's Endeavor BioMedicines nets $101M to hunt down genetic culprits of cancer

Biotech startup, launched in 2021, is pursuing a pipeline of precision medicines in oncology and idiopathic pulmonary fibrosis. ....

John Hood , Celgene Corp , Andrew Lam Group , Endeavor Biomedicines , San Diego Based Endeavor , Impact Biomedicines , Ally Bridge Group , Perceptive Advisors , Piper Heartland Healthcare Capital , Revelation Partners , Tekla Capital Management , Omega Funds , Longitude Capital , Andrew Lam , Rally Bridge ,

Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis

Endeavor BioMedicines aims to kill two birds with one stone that stone being a small molecule drug. Taladegib targets a cell signaling pathway associated with both cancer and idiopathic pulmonary fibrosis, and the biotech will apply its Series B round toward clinical tests of the molecule on both fronts. ....

John Hood , Eli Lilly , T Rowe Price Associates , Bridge Group , Avidity Partners , San Diego Based , Ally Bridge Group , Perceptive Advisors , Piper Heartland Healthcare Capital , Revelation Partners , Tekla Capital Management , Omega Funds , Longitude Capital , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It ,

Endeavor BioMedicines Gains $101M More For Precision Medicine

San Diego-based Endeavor BioMedicines, a clinical-stage biotechnology company focused on oncology and fibrosis, says it has raised $101M in its Series B funding round. The funding was led by A ....

T Rowe Price Associates Inc , Tekla Capital Management , Biomedicines Gains , More For Precision Medicine , Diego Based Endeavor Biomedicines , Ally Bridge Group , Avidity Partners , Perceptive Advisors , Piper Heartland Healthcare Capital , Revelation Partners , Price Associates , Omega Funds ,

HotSpot Therapeutics Raises $100M in Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

United States , Fouad Azzam , Jonathan Montagu , Atlas Venture , Monashee Investment Management , Tekla Capital Management , Ventures Fund , Hotspot Therapeutics Inc , B Capital Group , Hotspot Therapeutics , Venture Partners , Caas Capital Management , Revelation Partners , Pavilion Capital , Sofinnova Partners , Capital Management , Yash Khanna , Hotspot Board , Smart Allostery , Chief Executive Officer ,

HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic

/PRNewswire/ HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first-in-class allosteric therapies targeting. ....

United States , Fouad Azzam , Jonathan Montagu , Atlas Venture , Monashee Investment Management , Tekla Capital Management , Ventures Fund , Prnewswire Hotspot Therapeutics Inc , B Capital Group , Spot Therapeutics , Venture Partners , Caas Capital Management , Revelation Partners , Pavilion Capital , Sofinnova Partners , Capital Management , Yash Khanna , Hotspot Board , Smart Allostery , Chief Executive Officer , Venture Partner , Hotspot Therapeutics ,